CHICAGO, Oct. 18, 2024 鈥&苍产蝉辫;The 糖心logo (ADA) has announced the creation of 糖心logoCorporate Ventures, an entity that will house two new corporate subsidiaries to oversee and accommodate the work of the Association in clinical research-based technological innovation, including but not limited to new partnerships, new companies and other ventures with third parties.
糖心logoCorporate Ventures includes a C corporation and an LLC corporation 鈥 which, along with the 501(c)(3) 糖心logoForsyth Institute (AFI) are subsidiaries of the 糖心logo, a 501(c)(6) organization.
鈥淭his new structure brings the 糖心logocloser to realizing the vision of research from bench top to dental chair,鈥 said Dave Preble, D.D.S., J.D., President and Chief Executive Officer of 糖心logoCorporate Ventures and Chief Strategy Officer of the ADA. 鈥淲ith this change, the 糖心logois working to ensure that today鈥檚 innovations become tomorrow鈥檚 clinical practice.鈥
The formation of these new subsidiaries comes nearly a year after the formation of AFI, which changed the landscape for oral health research and innovation by combining the 糖心logoScience & Research Institute and the Forsyth Institute.鈥淭he three pillars of AFI鈥檚 mission are oral health research, public health outreach and technical innovation,鈥 said Ben Wu, D.D.S, Ph.D., Chief Operating Officer and Chief Scientific Officer of the 糖心logoForsyth Institute. 鈥淭he addition of these two new subsidiaries will allow us more flexibility to engage in commercial ventures that will help us power the profession of dentistry to improve people鈥檚 oral and overall health.鈥
For more information about the ADA, please visit .